Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia

TL;DR

A hospital's experience with multidisciplinary meetings for managing male urinary symptoms and prostate enlargement shows most recommendations are followed, but some cases deviate due to patient or clinical factors.

Contribution

Demonstrates the feasibility of multidisciplinary meetings for managing male lower urinary tract symptoms and benign prostate hyperplasia in a single academic center.

Findings

71% of recommendations from multidisciplinary meetings were implemented over one year.

90.7% of cases followed the consultant's proposal, while 8.3% resulted in different decisions.

Common reasons for not following recommendations included patient preference and unavailability of techniques.

Abstract

To describe a single academic centre experience in the establishment of Multidisciplinary Meetings (MDM) for the management of male non‐neurogenic Lower Urinary Tract Symptoms (LUTS) and Benign Prostate Hyperplasia (BPH).

Retrospective analysis of all the cases discussed in MDM for LUTS/BPH in our academic centre over a year, and analysis of the implementation rates, reasons for failure of implementation and discrepancies between the proposal and the final decision.

Over one year, 108 cases were discussed. The implementation rate of the recommendation was 71% (77/108). The reasons for the failure of implementation of the recommendation were patient preference in 6 (5%), lost to follow‐up in 13 (12%), consultant decision in 4 (4%), patient deterioration or new comorbidities in 2 (2%), improvement of LUTS symptoms in 4 (4%) and the suggested technique was not available for technical reasons in 1 (1%). The consultant's proposal was validated in 98 cases (90.7%) and a different decision was made in 9 cases (8.3%).

The establishment of a MDM for male LUTS/BPH is feasible and could contribute to the improvement of the management of patients. Further studies are needed to evaluate all its aspects.